BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Fatty acid metabolic process
,
HIV infection
,
Stem cell
,
Neocentromeres
,
Doxycycline
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
fev1 fvc ratio
Summary
General Info
Curated Studies
Most Correlated Studies
A COPD-related gene expression signature in squamous cell lung cancer
Explore Curated Studies Results
Literature
Most Relevant Literature
The Impact of FEV1/FVC Ratio on the Clinical Outcomes in Acute Coronary Syndrome Patients Treated wi…
The ratio FEV1 /FVC and its association to respiratory symptoms-A Swedish general population study.
The effect of teach-back training intervention of breathing exercise on the level of dyspnea, six-mi…
Prognostic implication of FEV1/FVC ratio for limited-stage small cell lung cancer.
Difference in Mortality Risk in Elderly People with Bronchial Obstruction Diagnosed Using a Fixed Cu…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Spiriva® Assessment of FEV1 (SAFE)
nCD64 vs. Neutrophil/Lymphocyte Ratio for Predicting In-hospital Outcome in AE-COPD
A Study to Evaluate the 24 Hour Spirometric Effect (FEV1) of Fluticasone Furoate/Vilanterol Inhalati…
The Purpose of This Study is to Evaluate the Spirometric Effect (Trough FEV1) of Umeclidinium/Vilant…
Efficacy of Fluticasone Propionate Associated With Salmeterol Using Inhalation Chamber Versus Placeb…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ